STML

Stemline Therapeutics, Inc.
STML

Overview Fund Activity
Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

98 hedge funds and large institutions have $436M invested in Stemline Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 15 closing their positions.

Holders
98
Holders Change
+6
Holders Change %
+6.52%
% of All Funds
2.12%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
21
Increased
42
Reduced
23
Closed
15
Calls
$365K
Puts
$2.78M
Net Calls
-$2.41M
Net Calls Change
-$1.69M

Top Buyers

1
RCMNY
1
Rubric Capital Management (New York)
New York
$38.6M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$45M
3
FCM
3
Farallon Capital Management
California
$25.7M
4
Goldman Sachs
4
Goldman Sachs
New York
$17.5M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$11.5M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
LSC
2
Lyon Street Capital
California
$545K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$11.8M
4
Citadel Advisors
4
Citadel Advisors
Florida
$381K
5
PC
5
Polar Capital
United Kingdom
$24.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$45M 3,500,000 +2,789,986 +393%
RCMNY
2
Rubric Capital Management (New York)
New York
$38.6M 3,005,000 +3,005,000 New
BlackRock
3
BlackRock
New York
$34.7M 2,703,489 +638,250 +31%
FCM
4
Farallon Capital Management
California
$25.7M 2,000,000 +2,000,000 New
PC
5
Polar Capital
United Kingdom
$24.4M 1,900,000 -402,666 -17%
Vanguard Group
6
Vanguard Group
Pennsylvania
$21.8M 1,695,687 +376,091 +29%
State Street
7
State Street
Massachusetts
$21.1M 1,641,900 +609,181 +59%
EAM
8
Eventide Asset Management
Massachusetts
$20.7M 1,609,523 +523,123 +48%
Goldman Sachs
9
Goldman Sachs
New York
$17.5M 1,363,968 +1,324,590 +3,364%
Manulife (Manufacturers Life Insurance)
10
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$15.6M 1,213,417 +129,824 +12%
Axa
11
Axa
France
$12.2M 945,567 +264,089 +39%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$11.8M 915,698 -531,100 -37%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$11.5M 892,586 +892,586 New
IBT
14
International Biotechnology Trust
United Kingdom
$10.2M 796,245 +210,315 +36%
SSA
15
Schonfeld Strategic Advisors
New York
$10.1M 782,100 +782,100 New
KAM
16
Kavi Asset Management
New York
$8.74M 680,200 +680,200 New
PC
17
Pier Capital
Connecticut
$8.22M 639,582 +215,915 +51%
MP
18
Mangrove Partners
Connecticut
$8.18M 636,513 +636,513 New
SAM
19
Sectoral Asset Management
Quebec, Canada
$7.66M 596,058 +557,220 +1,435%
Northern Trust
20
Northern Trust
Illinois
$6.61M 514,229 +119,727 +30%
Man Group
21
Man Group
United Kingdom
$5.82M 453,108 +453,108 New
CC
22
Carlson Capital
Texas
$5.79M 450,468 +450,468 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$5.68M 441,768 +130,441 +42%
AG
24
Artal Group
Luxembourg
$5.14M 400,000 – –
ELI
25
Empire Life Investments
Ontario, Canada
$4.8M 373,186 -677 -0.2%
1
2 3 4 5